Hyperion Defi (HYPD) Non-Current Assets (2016 - 2026)
Hyperion Defi (HYPD) posted quarterly Non-Current Assets of $61.3 million for Q1 2026, up 7325.97% year-over-year from $824970.0 in Q1 2025, and up 37.61% quarter-over-quarter from $44.5 million in Q4 2025.
Hyperion Defi (HYPD) Non-Current Assets (2016 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Non-Current Assets for 11 consecutive years, with $61.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets rose 7325.97% year-over-year to $61.3 million; the TTM figure through Mar 2026 stood at $225.8 million (up 819.83% YoY), while the FY2025 annual figure was $44.5 million, up 4843.42% from the prior year.
- Non-Current Assets climbed to $61.3 million in Q1 2026 per HYPD's latest filing, from $44.5 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $73.7 million in Q3 2025 and bottomed at $824970.0 in Q1 2025.
- Historically, Non-Current Assets has averaged $18.5 million across 5 years, with a median of $9.8 million in 2022.
- Annual changes were most pronounced in 2025 — Non-Current Assets tumbled 92.96% — and 2026, when it jumped 7325.97%.
- Hyperion Defi's Non-Current Assets stood at $3.4 million in 2022, then surged by 137.86% to $8.1 million in 2023, then slumped by 88.84% to $900560.0 in 2024, then surged by 4843.42% to $44.5 million in 2025, then soared by 37.61% to $61.3 million in 2026.
- Business Quant data shows HYPD's Non-Current Assets at $61.3 million in Q1 2026, $44.5 million in Q4 2025, and $73.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.29 Bn | 132.43 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 86.58 Bn | 78.58 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.08 Bn | 1.37 Bn | 1.96 Bn |
| 4 | Moderna | 61.87 Bn | 56.73 Bn | 52.00 Mn | 5.15 Bn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 1.96 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn | 938.60 Mn |
| 7 | BioNTech SE | 28.90 Bn | 10.51 Bn | 668.28 Mn | 6.80 Bn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 468.65 Mn |
| 9 | Royalty Pharma | 27.24 Bn | 26.41 Bn | - | 18.06 Bn |
| 10 | Hyperion Defi | 46.90 Mn | 37.26 Mn | 357,693.00 | 100.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100.23 Mn |
| Mar 31, 2026 | 61.26 Mn |
| Dec 31, 2025 | 44.52 Mn |
| Sep 30, 2025 | 73.70 Mn |
| Jun 30, 2025 | 46.27 Mn |
| Mar 31, 2025 | 824,970.00 |
| Dec 31, 2024 | 900,560.00 |
| Sep 30, 2024 | 11.11 Mn |
| Jun 30, 2024 | 11.71 Mn |
| Mar 31, 2024 | 11.73 Mn |
| Dec 31, 2023 | 8.07 Mn |
| Sep 30, 2023 | 8.33 Mn |
| Jun 30, 2023 | 6.07 Mn |
| Mar 31, 2023 | 4.39 Mn |
| Dec 31, 2022 | 3.39 Mn |
| Sep 30, 2022 | 1.99 Mn |
| Jun 30, 2022 | 9.99 Mn |
| Mar 31, 2022 | 9.79 Mn |
| Dec 31, 2021 | 9.66 Mn |
| Sep 30, 2021 | 1.53 Mn |